Unichem Laboratories is presently buying and selling at Rs. 194.80, up with the aid of three.Fifty five factors or 1.86% from its preceding final of Rs. 191.25 at the BSE.
The scrip opened at Rs. 198.05 and has touched a excessive and occasional of Rs. 198.05 and Rs. 194.20 respectively. So far 12760 stocks were traded at the counter.
The BSE institution ‘B’ inventory of face price Rs. 2 has touched a fifty two week high of Rs. 382.00 on 08-Jan-2018 and a fifty two week low of Rs. 182.00 on eleven-Oct-2018.
Last one week excessive and occasional of the scrip stood at Rs. 199.70 and Rs. 188.75 respectively. The modern-day market cap of the agency is Rs. 1367.Fifty five crore.
The promoters keeping within the organisation stood at 50.67%, whilst Institutions and Non-Institutions held 10.22% and 39.11% respectively.
Unichem Laboratories has acquired Tentative Approval for its Abbreviated New Drug Application (ANDA), Tadalafil Tablets, 2.5 mg, five mg 10 mg and 20 mg from the USA Food and Drug Administration (USFDA) for a well-known model of ELI LILLY’s Cialis, 2.Five mg, five mg, 10 mg and 20 mg.
The company’s Tadalafil Tablets are indicated for the remedy of erectile disorder (ED) and treatment of the symptoms and symptoms of benign prostatic hyperplasia (BPH) and the treatment of ED and the symptoms and signs and symptoms of BPH (ED/BPH).
Bazaarinformation team has many years of experience, covering the physical and future commodities markets with prominent commodity & equity trading advising which shines further with extensive network to get research from ground levels to generate proper reporting and movements. We are able to get evens out of odds in volatile markets and stockings. ...
